BACKGROUND: Hypertensive disorders account for 14% of global maternal deaths. Magnesium sulphate (MgSO4 ) is recommended for prevention and treatment of pre-eclampsia/eclampsia. However, MgSO4 remains underused, particularly in low- and middle-income countries (LMICs). OBJECTIVE: This qualitative evidence synthesis explores perceptions and experiences of healthcare providers, administrators and policy-makers regarding factors affecting use of MgSO4 to prevent or treat pre-eclampsia/eclampsia. SEARCH STRATEGY: We searched MEDLINE, EMBASE, Emcare, CINAHL, Global Health and Global Index Medicus, and grey literature for studies published between January 1995 and June 2021. SELECTION CRITERIA: Primary qualitative and mixed-methods studies on fac...
Introduction: The hypertensive disorders in pregnancy are the leading causes of maternal and perinat...
INTRODUCTION:Magnesium sulfate (MgSO4) is the drug of choice for the prevention and control of seizu...
Background: Preeclampsia was reported to account for 15 % of all antenatal hospitalization for pregn...
<div><p>Objective</p><p>Magnesium sulphate is recommended by international guidelines to prevent ecl...
OBJECTIVE: To characterise the current clinical practice patterns regarding the use of magnesium sul...
OBJECTIVE: To review systematically the magnesium sulphate (MgSO4) dosing regimens tested in low and...
Introduction: Magnesium sulfate (MgSC4) is the agent most commonly used for treatment of eclampsia a...
Global studies have demonstrated that using magnesium sulphate (MgSO4) to manage hypertensive diseas...
Severe pre-eclampsia and eclampsia are rare but serious complications of pregnancy that threaten the...
Objective: To establish a baseline of magnesium sulfate utilization prior to publication of the upda...
Objectives: The use of magnesium sulfate (MgSO4) in European obstetric units is unknown. We aimed to...
Objectives: The use of magnesium sulfate (MgSO4) in European obstetric units is unknown. We aimed to...
Eclampsia is the main cause of maternal death in Brazil. Magnesium sulfate is the drug of choice for...
Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in rn Nigeri...
Severe pre-eclampsia and eclampsia are common causes of maternal deaths worldwide and more so in dev...
Introduction: The hypertensive disorders in pregnancy are the leading causes of maternal and perinat...
INTRODUCTION:Magnesium sulfate (MgSO4) is the drug of choice for the prevention and control of seizu...
Background: Preeclampsia was reported to account for 15 % of all antenatal hospitalization for pregn...
<div><p>Objective</p><p>Magnesium sulphate is recommended by international guidelines to prevent ecl...
OBJECTIVE: To characterise the current clinical practice patterns regarding the use of magnesium sul...
OBJECTIVE: To review systematically the magnesium sulphate (MgSO4) dosing regimens tested in low and...
Introduction: Magnesium sulfate (MgSC4) is the agent most commonly used for treatment of eclampsia a...
Global studies have demonstrated that using magnesium sulphate (MgSO4) to manage hypertensive diseas...
Severe pre-eclampsia and eclampsia are rare but serious complications of pregnancy that threaten the...
Objective: To establish a baseline of magnesium sulfate utilization prior to publication of the upda...
Objectives: The use of magnesium sulfate (MgSO4) in European obstetric units is unknown. We aimed to...
Objectives: The use of magnesium sulfate (MgSO4) in European obstetric units is unknown. We aimed to...
Eclampsia is the main cause of maternal death in Brazil. Magnesium sulfate is the drug of choice for...
Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in rn Nigeri...
Severe pre-eclampsia and eclampsia are common causes of maternal deaths worldwide and more so in dev...
Introduction: The hypertensive disorders in pregnancy are the leading causes of maternal and perinat...
INTRODUCTION:Magnesium sulfate (MgSO4) is the drug of choice for the prevention and control of seizu...
Background: Preeclampsia was reported to account for 15 % of all antenatal hospitalization for pregn...